Natco Pharma (NSE:NATCOPHARM) Dividend Payout Ratio: 0.10 (As of Mar. 2026) — 44% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:NATCOPHARM Natco Pharma Ltd NSE:NATCOPHARM
89 GF Score
Price ₹945.00
GF Value ₹929.10
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Natco Pharma Dividend Payout Ratio?

Natco Pharma NSE:NATCOPHARM -2.19% 89 Dividend Payout Ratio is 0.10 as of Mar. 2026, which is 44% below its 10-year median of 0.18. GuruFocus rates NSE:NATCOPHARM with a GF Score™ of 89/100 and a GF Value™ of ₹929.10 (Fairly Valued). The stock has 2 warning signs investors should review. Among 445 Drug Manufacturers companies, Natco Pharma ranks better than 95.96% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Natco Pharma's Dividend Payout Ratio for the months ended in Mar. 2026 was 0.10.

The historical rank and industry rank for Natco Pharma's Dividend Payout Ratio or its related term are showing as below:

NSE:NATCOPHARM' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.06   Med: 0.18   Max: 0.55
Current: 0.06

During the past 13 years, the highest Dividend Payout Ratio of Natco Pharma was 0.55. The lowest was 0.06. And the median was 0.18.

NSE:NATCOPHARM's Dividend Payout Ratio is ranked better than
95.96% of 445 companies
in the Drug Manufacturers industry
Industry Median: 0.38 vs NSE:NATCOPHARM: 0.06

As of today (2026-07-18), the Dividend Yield % of Natco Pharma is 0.53%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Natco Pharma was 1.50%. The lowest was 0.18%. And the median was 0.75%.

Natco Pharma's Dividends per Share for the months ended in Mar. 2026 was ₹1.50.

During the past 12 months, Natco Pharma's average Dividends Per Share Growth Rate was -16.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -3.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 0.80% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 6.20% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Natco Pharma was 102.10% per year. The lowest was -8.80% per year. And the median was 15.50% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Natco Pharma (NSE:NATCOPHARM) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Natco Pharma Dividend Payout Ratio Related Terms

Natco Pharma Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Natco Pharma's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Natco Pharma Dividend Payout Ratio Chart

Natco Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.55 0.14 0.12 0.06 0.06

Natco Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.00 0.07 0.18 0.10

NSE:NATCOPHARM vs ZTS, UTHR: Dividend Payout Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Natco Pharma's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Natco Pharma Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Natco Pharma's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Natco Pharma's Dividend Payout Ratio falls into.


NSE:NATCOPHARM
89GF Score
Natco Pharma Ltd NSE:NATCOPHARM
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Natco Pharma Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Natco Pharma's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2026 )/ EPS without NRI (A: Mar. 2026 )
=5/ 79.2
=0.06

Natco Pharma's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=1.5/ 14.96
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.10 mean?
Natco Pharma (NSE:NATCOPHARM) has a Dividend Payout Ratio of 0.10 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Natco Pharma and its competitors. This is 44% below median its historical median of 0.18. Over the past decade, Natco Pharma's Dividend Payout Ratio has ranged from 0.06 to 0.55. According to the industry distribution chart, Natco Pharma ranks #18 out of 445 companies in the Drug Manufacturers industry, placing it in the top 4%.
Is Natco Pharma's Dividend Payout Ratio too high?
Natco Pharma's current Dividend Payout Ratio of 0.10 is 44% below median its 10-year median of 0.18. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 0.55. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Natco Pharma's value of 0.10 is 73.7% below this industry median. Based on the distribution chart, Natco Pharma ranks #18 out of 445 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Natco Pharma has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Natco Pharma's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Natco Pharma ranks #18 out of 445 companies for Dividend Payout Ratio. This places Natco Pharma in the top 4% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.38. Natco Pharma's value of 0.10 is 73.7% below this benchmark. Historically, Natco Pharma's own Dividend Payout Ratio has ranged from 0.06 to 0.55 over the past decade. While the company's 10-year median is 0.18 vs. the industry median of 0.38, Natco Pharma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 445 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Natco Pharma's current Dividend Payout Ratio of 0.10 is 73.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Natco Pharma and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Natco Pharma's current Dividend Payout Ratio is 0.10, which is 44% below median its own 10-year median of 0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Natco Pharma stock overvalued right now?
Based on GuruFocus' analysis, Natco Pharma (NSE:NATCOPHARM) is currently considered Fairly Valued. The stock's GF Value™ is ₹929.10, compared to a current price of ₹945.00 — trading 1.7% above its estimated fair value. The current Dividend Payout Ratio is 0.10, which is 44% below median its 10-year median of 0.18 and 73.7% below the Drug Manufacturers industry median of 0.38. Natco Pharma's overall GF Score™ is 89/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Natco Pharma (NSE:NATCOPHARM), the current Dividend Payout Ratio is 0.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Natco Pharma (NSE:NATCOPHARM) Overvalued in 2026?

Based on GuruFocus' analysis, Natco Pharma stock appears to be overvalued. The current stock price of ₹945.00 is trading 1.7% above its estimated GF Value™ of ₹929.10. GuruFocus considers Natco Pharma to be Fairly Valued.

Key valuation signals for NSE:NATCOPHARM:

  • Dividend Payout Ratio: 0.10 (44% below median its 10-year median of 0.18)
  • GF Value™: ₹929.10 vs. price of ₹945.00 (1.7% above fair value)
  • GF Score™: 89/100 with 2 warning signs
  • Industry Position: 73.7% below the Drug Manufacturers median (#18 of 445)

No single metric tells the full story. See the NSE:NATCOPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Natco Pharma Business Description

Other Exchanges 524816:India
Address Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, IND, 500034
Natco Pharma Ltd is a drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. It derives maximum revenue from Pharmaceuticals Segment.
89GF Score

Get the complete analysis for NSE:NATCOPHARM

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹945.00
Price
₹929.10
GF Value